Rivercell has secured $25 million in a seed round led by HV to build data platforms and AI models that predict human cell responses to treatment.
Amount Raised
$25 Million
Round Type
Seed
Investors
Description
Rivercell, based in Paris, focuses on biotechnology and artificial intelligence. The company has announced a successful seed round of $25 million, which will be used to develop innovative data platforms and AI models. HV led this funding round, marking a significant milestone for Rivercell. The investment aims to enhance treatment prediction capabilities for human cells.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Rivercell that raised within 45 days of this round, from Fundz verified event records.
- Kardi Ai raised $5.9M (Series A) on November 11, 2026.
- Alterra Labs raised $13M (Seed) on November 10, 2026.
- Laza Medical raised $160M (Series B) on November 4, 2026.
- Pathos AI raised $237M (Series E) on October 23, 2026.
- Scarlet raised $50M (Series B) on October 12, 2026.
- AIBORN Ltd raised an undisclosed amount on October 5, 2026.
Who to call at Rivercell, and when
A new round usually means Rivercell is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Rivercell raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Rivercell, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Rivercell. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Rivercell raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Rivercell raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.